ISRCTN72387688已完成未知
Probiotic VSL#3 as a treatment for food intolerant irritable bowel syndrome (IBS)
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 20
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- All
入选标准
- •20 subjects aged 18 - 65 years, either sex
排除标准
- •Not provided at time of registration
研究者
相似试验
已完成
不适用
Probiotic VSL#3 for the Treatment of Gastrointestinal Symptoms Associated to FibromyalgiaGastrointestinal DiseaseFibromyalgiaNCT04256785Elena Pita Calandre110
已完成
不适用
Probiotic effect on prevention of feeding intoleranceFeeding intolerance.Diseases of the Digestive systemIRCT2015111925125N1Babol University of Medical Sciences60
已完成
2 期
Probiotic preparation, VSL#3 as a support pharmaceutical therapy in cirrhotic patients for the treatment of minimal hepatic encephalopathy (MHE)CTRI/2008/091/000268CD Pharma India Pvt Ltd
已完成
4 期
Effect of VSL#3 (Original De Simone Formulation) on Cognitive Function, Risk of Falls and Quality of Life in Patients With CirrhosisCognitive DysfunctionCirrhosisNCT01686698Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau40
终止
2 期
Probiotic (VSL #3) for Gulf War IllnessGulf War IllnessNCT02011542University of Utah29